• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Pathological lesions of Alzheimer's disease and dementia with Lewy bodies brains exhibit immunoreactivity to an ATPase that is a regulatory subunit of the 26S proteasome.

作者信息

Fergusson J, Landon M, Lowe J, Dawson S P, Layfield R, Hanger D P, Mayer R J

机构信息

Department of Biochemistry, University of Nottingham Medical School, Queen's Medical Centre, UK.

出版信息

Neurosci Lett. 1996 Nov 29;219(3):167-70. doi: 10.1016/s0304-3940(96)13192-x.

DOI:10.1016/s0304-3940(96)13192-x
PMID:8971806
Abstract

MS73 is one of a family of ATPases that act as regulatory subunits of the 26S proteasome. Localisation of this ATPase in histological sections of hippocampus from Alzheimer's disease (AD) and in cingulate gyrus sections of dementia with Lewy bodies (DLB) brains was examined immunohistochemically. In all cases of AD (n = 10) neurofibrillary tangles (NFT), plaque neurites and neuropil threads were immunoreactive for MS73. In seven out of the nine cases of DLB, distinctive MS73-positive structures were detected within cortical Lewy bodies. The association of MS73 with these neuronal abnormalities provides further evidence that proteolytic processing involving the 26S proteasome occurs in lesions of AD and DLB.

摘要

相似文献

1
Pathological lesions of Alzheimer's disease and dementia with Lewy bodies brains exhibit immunoreactivity to an ATPase that is a regulatory subunit of the 26S proteasome.
Neurosci Lett. 1996 Nov 29;219(3):167-70. doi: 10.1016/s0304-3940(96)13192-x.
2
Pathological entity of dementia with Lewy bodies and its differentiation from Alzheimer's disease.路易体痴呆的病理实体及其与阿尔茨海默病的鉴别
Acta Neuropathol. 2004 Aug;108(2):121-8. doi: 10.1007/s00401-004-0869-4. Epub 2004 May 14.
3
Alpha-synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease beta-amyloid plaque cores.α-突触核蛋白在帕金森病和路易体痴呆的路易小体中聚集，但在阿尔茨海默病的β-淀粉样蛋白斑块核心中不聚集。
Neurosci Lett. 1999 May 14;266(3):213-6. doi: 10.1016/s0304-3940(99)00311-0.
4
Lewy body variant of Alzheimer's disease and Alzheimer's disease: a comparative immunohistochemical study.阿尔茨海默病路易体变异型与阿尔茨海默病：一项比较性免疫组织化学研究。
Folia Neuropathol. 2001;39(2):63-71.
5
Distribution of cerebral amyloid deposition and its relevance to clinical phenotype in Lewy body dementia.路易体痴呆症中脑淀粉样蛋白沉积的分布及其与临床表型的相关性。
Neurosci Lett. 2010 Dec 3;486(1):19-23. doi: 10.1016/j.neulet.2010.09.036. Epub 2010 Sep 17.
6
Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies.散发性帕金森病和路易体痴呆患者路易小体中磷酸化tau蛋白和NACP/α-突触核蛋白表位的细胞共定位。
Brain Res. 1999 Oct 2;843(1-2):53-61. doi: 10.1016/s0006-8993(99)01848-x.
7
The 26S-proteasome: regulation and substrate recognition.26S蛋白酶体：调控与底物识别
Mol Biol Rep. 1997 Mar;24(1-2):39-44. doi: 10.1023/a:1006800522814.
8
Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies.聚集素/载脂蛋白J与皮质路易小体相关：α-突触核蛋白病病例的免疫组织化学研究
Acta Neuropathol. 2002 Sep;104(3):225-30. doi: 10.1007/s00401-002-0546-4. Epub 2002 May 9.
9
The spatial patterns of Lewy bodies, senile plaques, and neurofibrillary tangles in dementia with Lewy bodies.路易体痴呆中路易体、老年斑和神经原纤维缠结的空间分布模式。
Exp Neurol. 1998 Mar;150(1):122-7. doi: 10.1006/exnr.1997.6761.
10
Expression of a 26S proteasome ATPase subunit, MS73, in muscles that undergo developmentally programmed cell death, and its control by ecdysteroid hormones in the insect Manduca sexta.26S蛋白酶体ATP酶亚基MS73在经历程序性细胞死亡的肌肉中的表达及其在烟草天蛾中受蜕皮甾体激素的调控。
FEBS Lett. 1997 Jan 6;400(3):345-9. doi: 10.1016/s0014-5793(96)01413-5.

引用本文的文献

1
Upregulation of PSMB8 and cathepsins in the human brains of dementia with Lewy bodies.路易体痴呆患者大脑中PSMB8和组织蛋白酶的上调。
Neurosci Lett. 2018 Jun 21;678:131-137. doi: 10.1016/j.neulet.2018.05.022.
2
The Prenylflavonoid Xanthohumol Reduces Alzheimer-Like Changes and Modulates Multiple Pathogenic Molecular Pathways in the Neuro2a/APP Cell Model of AD.异戊烯基黄酮黄腐酚可减轻阿尔茨海默氏症样变化，并调节AD的Neuro2a/APP细胞模型中的多种致病分子途径。
Front Pharmacol. 2018 Apr 4;9:199. doi: 10.3389/fphar.2018.00199. eCollection 2018.
3
Polyubiquitinylation Profile in Down Syndrome Brain Before and After the Development of Alzheimer Neuropathology.
唐氏综合征患者大脑在阿尔茨海默病神经病理学发展前后的多聚泛素化谱
Antioxid Redox Signal. 2017 Mar 1;26(7):280-298. doi: 10.1089/ars.2016.6686. Epub 2016 Oct 26.
4
Sirtuins and proteolytic systems: implications for pathogenesis of synucleinopathies.沉默调节蛋白与蛋白水解系统：对突触核蛋白病发病机制的影响。
Biomolecules. 2015 May 4;5(2):735-57. doi: 10.3390/biom5020735.
5
The Lewy body in Parkinson's disease and related neurodegenerative disorders.路易体在帕金森病及相关神经退行性疾病中的作用。
Mol Neurobiol. 2013 Apr;47(2):495-508. doi: 10.1007/s12035-012-8280-y. Epub 2012 May 24.
6
The last tangle of tau.tau蛋白的最后缠结
J Alzheimers Dis. 2008 Aug;14(4):441-7. doi: 10.3233/jad-2008-14413.
7
Histone deacetylase 6 interacts with the microtubule-associated protein tau.组蛋白去乙酰化酶6与微管相关蛋白tau相互作用。
J Neurochem. 2008 Sep;106(5):2119-30. doi: 10.1111/j.1471-4159.2008.05564.x. Epub 2008 Jul 12.
8
Intraneuronal dopamine-quinone synthesis: a review.神经元内多巴胺-醌的合成：综述
Neurotox Res. 2000 Feb;1(3):181-95. doi: 10.1007/BF03033289.
9
Significance of the parkin gene and protein in understanding Parkinson's disease.帕金基因和蛋白在理解帕金森病中的意义。
Curr Neurol Neurosci Rep. 2002 Jul;2(4):296-302. doi: 10.1007/s11910-002-0004-7.
10
Degradation of soluble amyloid beta-peptides 1-40, 1-42, and the Dutch variant 1-40Q by insulin degrading enzyme from Alzheimer disease and control brains.
Neurochem Res. 2000 Feb;25(2):247-55. doi: 10.1023/a:1007527721160.